title: Growth hormone receptor and IGF-I receptor immunoreactivity during orthodontic tooth movement in the prednisolone-treated rat.
abstract: Bone remodeling during tooth movement is regulated by local and systemic factors. Two regulators of bone metabolism are growth hormone (GH) and insulin-like growth factor-I (IGF-I). Their effects are mediated via binding to GH receptor (GHR) and IGF-I receptor (IGF-IR) in target tissues. Corticosteroids may affect the activity of these growth factors. This study examined the effect of prednisolone on GHR and IGF-IR expression in dental tissues following orthodontic tooth movement. The corticosteroid-treated group (N = 6) was administered prednisolone (1 mg/kg) daily and the control group (N = 6) received equivalent volumes of saline. An orthodontic force (30 g) was applied to the maxillary first molar. Animals were sacrificed 12 days postappliance insertion. Sagittal sections of the first molar were stained for GHR and IGF-IR immunoreactivity. GHR and IGF-IR cell counts were elevated following appliance-treatment. Orthodontic tooth movement appeared to up-regulate GHR and IGF-IR immunoreactivity, but this up-regulation was reduced following prednisolone treatment. The suppression of GHR and IGF-I immunoreactivity in steroid-treated animals infers the mechanism whereby bone resorption and deposition, necessary for orthodontic tooth movement, may be inhibited by prednisolone. However, at 12 days postappliance insertion, no difference in orthodontic tooth movement was observed following low-dose prednisolone treatment.
authors.affiliation: School of Dentistry, The University of Queensland, Brisbane, Australia.
authors.forename: C K
authors.initials: CK
authors.lastname: Ong
authors.forename: B K
authors.initials: BK
authors.lastname: Joseph
authors.forename: M J
authors.initials: MJ
authors.lastname: Waters
authors.forename: A L
authors.initials: AL
authors.lastname: Symons
mesh_terms: D000539:Alveolar Process / Q000378:metabolism; D000704:Analysis of Variance; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D016723:Bone Remodeling / Q000187:drug effects*; D007124:Immunoenzyme Techniques; D008297:Male; D008963:Molar / Q000378:metabolism; D011239:Prednisolone / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D017526:Receptor, IGF Type 1 / Q000096:biosynthesis*; D011986:Receptors, Somatotropin / Q000096:biosynthesis*; D014087:Tooth Movement Techniques; D014092:Tooth Root / Q000378:metabolism; D015854:Up-Regulation
chemical_list: D000893:Anti-Inflammatory Agents; D011986:Receptors, Somatotropin; D011239:Prednisolone; D017526:Receptor, IGF Type 1